Rimke Oostvogels

798 total citations
24 papers, 369 citations indexed

About

Rimke Oostvogels is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Rimke Oostvogels has authored 24 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Rimke Oostvogels's work include T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Rimke Oostvogels is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Rimke Oostvogels collaborates with scholars based in Netherlands, Belgium and United States. Rimke Oostvogels's co-authors include Tuna Mutis, H M Lokhorst, Monique C. Minnema, Eric Spierings, Robbert M. Spaapen, Jürgen Kuball, Zsolt Sebestyén, Wouter Scheper, Coraline Chéneau and Daniel Olive and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Rimke Oostvogels

22 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rimke Oostvogels Netherlands	11	254	159	90	73	47	24	369
Zhihua Tian China	5	280 1.1×	107 0.7×	169 1.9×	40 0.5×	54 1.1×	8	404
Manfred Smetak Germany	9	465 1.8×	357 2.2×	62 0.7×	56 0.8×	63 1.3×	17	573
Gabriel Brisou France	8	278 1.1×	101 0.6×	47 0.5×	129 1.8×	83 1.8×	20	425
Masanori Makita Japan	7	139 0.5×	168 1.1×	56 0.6×	80 1.1×	90 1.9×	21	270
Natalie Schub Germany	8	88 0.3×	143 0.9×	164 1.8×	56 0.8×	26 0.6×	21	292
Yusuke Meguri Japan	9	186 0.7×	112 0.7×	81 0.9×	27 0.4×	29 0.6×	32	285
Florence Orlanducci France	11	406 1.6×	227 1.4×	89 1.0×	42 0.6×	69 1.5×	23	481
Nobuhiko Tominaga Japan	9	122 0.5×	109 0.7×	82 0.9×	108 1.5×	77 1.6×	19	285
Noa Tal Israel	6	124 0.5×	100 0.6×	164 1.8×	63 0.9×	48 1.0×	11	356
H. T. Kim United States	7	131 0.5×	93 0.6×	134 1.5×	77 1.1×	108 2.3×	7	358

Countries citing papers authored by Rimke Oostvogels

Since Specialization

Citations

This map shows the geographic impact of Rimke Oostvogels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimke Oostvogels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimke Oostvogels more than expected).

Fields of papers citing papers by Rimke Oostvogels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rimke Oostvogels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimke Oostvogels. The network helps show where Rimke Oostvogels may publish in the future.

Co-authorship network of co-authors of Rimke Oostvogels

This figure shows the co-authorship network connecting the top 25 collaborators of Rimke Oostvogels. A scholar is included among the top collaborators of Rimke Oostvogels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rimke Oostvogels. Rimke Oostvogels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brink, Mirian, Wouter J. Plattel, Joost S.P. Vermaat, et al.. (2024). Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands. SHILAP Revista de lepidopterología. 5(6). 1215–1222.

Brink, Mirian, Marjolein van der Poel, Marie José Kersten, et al.. (2024). Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry. Blood Advances. 8(14). 3619–3628. 7 indexed citations

Brink, Mirian, Wouter J. Plattel, Marjolein van der Poel, et al.. (2023). Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands. Haematologica. 109(4). 1163–1170. 5 indexed citations

Brink, Mirian, Marjolein van der Poel, Marie José Kersten, et al.. (2022). Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study. Blood. 140(9). 1009–1019. 31 indexed citations

Brink, Mirian, Marjolein van der Poel, Marie José Kersten, et al.. (2022). Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis. European Journal of Cancer. 176. 100–109. 6 indexed citations

Brink, Mirian, Marie José Kersten, Pim Mutsaers, et al.. (2022). P1209: INCIDENCE, TREATMENT AND OUTCOME OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS. HemaSphere. 6. 1095–1096. 1 indexed citations

Scheper, Wouter, Tineke Aarts‐Riemens, Dennis X. Beringer, et al.. (2021). Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Molecular Therapy — Methods & Clinical Development. 22. 388–400. 5 indexed citations

Johanna, Inez, Sabine Heijhuurs, Wouter Scheper, et al.. (2021). Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Frontiers in Immunology. 12. 752699–752699. 2 indexed citations

Pont, Margot J., Rimke Oostvogels, Cornelis A.M. van Bergen, et al.. (2019). T Cells Specific for an Unconventional Natural Antigen Fail to Recognize Leukemic Cells. Cancer Immunology Research. 7(5). 797–804. 8 indexed citations

10.

Oostvogels, Rimke, Margot Jak, Reinier Raymakers, Rogier Mous, & Monique C. Minnema. (2018). Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients. British Journal of Haematology. 183(1). 60–67. 21 indexed citations

11.

Roeven, Mieke W.H., Willemijn Hobo, Remco van Doorn, et al.. (2017). A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma. Bone Marrow Transplantation. 52(10). 1378–1383. 23 indexed citations

12.

Oostvogels, Rimke, et al.. (2017). In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review. Bone Marrow Transplantation. 52(9). 1233–1240. 4 indexed citations

13.

Oostvogels, Rimke, Monique C. Minnema, Maarten E. Emmelot, et al.. (2016). Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients. Bone Marrow Transplantation. 52(2). 228–237. 24 indexed citations

14.

Sebestyén, Zsolt, Wouter Scheper, Siyi Gu, et al.. (2016). RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor. Cell Reports. 15(9). 1973–1985. 93 indexed citations

15.

Oostvogels, Rimke, H M Lokhorst, & Tuna Mutis. (2015). Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives. Bone Marrow Transplantation. 51(2). 163–171. 22 indexed citations

16.

Oostvogels, Rimke, H M Lokhorst, Monique C. Minnema, et al.. (2014). Identification of minor histocompatibility antigens based on the 1000 Genomes Project. Haematologica. 99(12). 1854–1859. 23 indexed citations

17.

Oostvogels, Rimke, Hans Kemperman, Isabelle Hubeek, & E.W.M.T. ter Braak. (2013). The importance of the osmolality gap in ethylene glycol intoxication. BMJ. 347(nov27 1). f6904–f6904. 4 indexed citations

18.

Oostvogels, Rimke, et al.. (2012). Systemic vasculitis in myelodysplastic syndromes.. PubMed. 70(2). 63–8. 12 indexed citations

19.

Oostvogels, Rimke, Monique C. Minnema, Robbert M. Spaapen, et al.. (2012). Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia. 27(3). 642–649. 22 indexed citations

20.

Broekhuizen, Berna DL, A. P. E. Sachs, Rimke Oostvogels, et al.. (2009). The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review. Family Practice. 26(4). 260–268. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact